Skip to main content
Jonathan Fletcher, MD, Medical Genetics, Boston, MA, Brigham and Women's Hospital

JonathanAlfredFletcherMD

Medical Genetics Boston, MA

Clinical Cytogenetics

Associate Professor of Pathology, Brigham and Women's Hospital

Dr. Fletcher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Fletcher's full profile

Already have an account?

  • Office

    75 Francis St
    Brigham And Womens Hospital Department Of Pathology
    Boston, MA 02115
    Phone+1 617-732-7883
  • Is this information wrong?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1986 - 1988
  • Boston University Medical Center
    Boston University Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1986
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 1981 - 1985
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1981

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1985 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Medical Genetics and Genomics Clinical Cytogenetics

Publications & Presentations

PubMed

Journal Articles

  • LMTK3 Is Essential for Oncogenic KIT Expression in KIT-Mutant GIST and Melanoma  
    Jonathan A Fletcher, William H Fleming, Nature

Press Mentions

  • Demetri’s Team Approach Translates into Success in Sarcoma Research
    Demetri’s Team Approach Translates into Success in Sarcoma ResearchFebruary 10th, 2016

Grant Support

  • Core--Molecular CytogeneticsNational Cancer Institute2000–2002
  • Translocation Of 8-13 In Stem-Cell Leukemia/LymphomaNational Cancer Institute1997–1999
  • Tumor Suppressor Loci In MesotheliomaNational Cancer Institute1996–1998
  • Molecular Cytogenetics Of Solid TumorsNational Cancer Institute1990–1994

Hospital Affiliations